A positive IgM test indicates that you may have been infected or that you have recently been vaccinated and your immune system has started responding to the vaccination and that your immune system has started responding to the virus.

Detection of rubella IgM by enzyme immunoassay (EIA) is used to confirm suspected cases of acute rubella infection and congenital rubella syndrome (CRS).

0.8 AI or less: Negative 0.9-1.0 AI: Equivocal - Repeat testing in 10-14 days may be helpful. 1.1 AI or greater: Positive

Interpretation of the Anti-Rubella IgM test involves considering several factors to determine the likelihood of recent Rubella virus infection: Positive IgM Test: A positive result for Anti-Rubella IgM antibodies suggests recent or acute Rubella virus infection. IgM antibodies typically appear within 7-10 days after infection and may persist for several weeks to months. However, false positives can occur, so clinical correlation with symptoms and other laboratory findings is essential. Confirmation with additional tests, such as PCR or IgG avidity testing, may be necessary. Negative IgM Test: A negative result for Anti-Rubella IgM antibodies suggests the absence of recent Rubella virus infection. However, a negative result does not necessarily rule out Rubella infection, particularly if the test is performed late in the course of illness when IgM levels may have declined. In cases of suspected Rubella infection with negative IgM results, repeat testing or additional diagnostic methods may be warranted. Interpretation with IgG Test: IgG antibodies against Rubella virus typically indicate past infection or immunity due to vaccination. The presence of IgG antibodies, along with a negative IgM test, suggests past immunity rather than recent infection. Clinical Context: Interpretation of the Anti-Rubella IgM test should be done in conjunction with the patient's clinical presentation, including symptoms and exposure history. Consultation with a healthcare provider, preferably an infectious disease specialist, is important for accurate diagnosis and appropriate management. Pregnancy Considerations: Rubella infection during pregnancy can have serious consequences for the fetus (Congenital Rubella Syndrome). In pregnant women, a positive IgM test for Rubella warrants further evaluation and monitoring to assess the risk to the fetus. Vaccination against Rubella is contraindicated during pregnancy, so accurate diagnosis and counseling are crucial. In summary, interpretation of the Anti-Rubella IgM test results requires careful consideration of clinical context, timing of testing, and correlation with other laboratory findings to determine the likelihood of recent Rubella virus infection.

Blood